12 Sha'aban 1445 - 23 February 2024
Sign up for newsletter
Eye of Dubai
Healthcare | Tuesday 29 September, 2015 2:48 am |


Under the patronage of His Highness Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai, UAE, Minister of Finance, and President of Dubai Health Authority; and supported by Sheikh Hamdan bin Rashid al Maktoum Award for Medical Sciences, the 5th Annual Case Based Approach to Controversies in Cardiovascular Disease Conference will take place in Dubai  from 8 -10 October 2015.  

The conference, organized by Cleveland Clinic and Mayo Clinic in cooperation with Emirates Cardiac Society, is accredited for 14 Continuous Medical Education hours from UAE University and will take place at the Mohammed Bin Rashid Academic Medical Center in Dubai Healthcare City. The conference will offer timely updates on significant advances in the prevention, diagnosis and treatment of cardiovascular disease, and all topics will be presented in a “real world” case-based format, which encourages participation and debate among the faculty and attendees. Course directors and speakers come from Mayo Clinic and Cleveland Clinic in the USA, and will be joined by prominent physicians in the cardiovascular field from the UAE. 

Wael Jaber, M.D., course director and staff cardiologist at Cleveland Clinic’s Heart & Vascular Institute, said, “We are proud that the conference will be held under the patronage of His Highness Sheikh Hamdan bin Rashid Al Maktoum, the patron and supporter of continuing medical education in the UAE. This comes in line with His Highness keenness on enhancing the skills of physicians and developing their professional performance which are essential factors to continuously upgrade health care services provided by healthcare organizations to the UAE population, following the latest scientific developments and technologies.”


“It’s a privilege to return to the UAE for this important conference on cardiovascular diseases, the number one cause of death globally,” said Joseph F. Maalouf, M.D., course director and cardiologist at Mayo Clinic. "We’re excited to collaborate with our peers at Cleveland Clinic to share expertise and new approaches to advance cardiovascular care.”  


Walid Saliba, M.D., course director of the conference and cardiologist in Cleveland Clinic, USA, said, “The conference will comprise valuable and up-to-date topics in the cardiovascular field that are relevant to the medical disciplines being addressed in the region. Our team of speakers aims to share our knowledge and the recent updates with the conviction that this will allow healthcare professionals to take better care of their patients.  We’re proud to bring our expertise to the Middle East region, and specifically to the United Arab Emirates, in collaboration with the Mayo Clinic.”


The three-day conference will host up to 300 attendees and is open to all health care professionals from the region who are involved in the management of patients with cardiovascular disease, including cardiologists, cardiac surgeons, internists, residents, fellows, physician assistants, nurses and other allied health professionals involved in the care of cardiovascular patients. The conference is also open for medical students with an interest in cardiothoracic surgery and cardiology.


Sessions will focus on cardiovascular diseases, electrophysiology, coronary artery disease, valvular disease, heart failure, and lipid management. Physicians will discuss real male and female patient cases from different age groups and different conditions. One satellite symposium will be dedicated to preventive cardiology and emerging therapies for dyslipidemia; and another one will focus on new developments for stroke prevention in atrial fibrillation. Several sessions will focus on women and young pregnant women with heart problems and chest pain. One of the speakers will also give an update on a case about a patient with heart failure that was discussed during last year’s conference. 


The speakers will assess the benefits and limitations of the current standard of care for the treatment of heart failure, and will discuss the wider applicability and potential impact of emerging percutaneous valve technology on the treatment of aortic stenosis and mitral regurgitation. They will also analyze the impact of gender differences in the management of cardiovascular diseases; review ventricular tachycardia storm, occurrence, management, and outcomes; summarize the current recommendations for the use of old and new anticoagulants and antiplatelet agents in atrial fibrillation; and develop a general understanding of who to refer for transcutaneous aortic valve replacement (TAVR).

Alongside the conference, there will be an exhibit, providing attendees exposure to the most cutting-edge technologies, resources and treatment solutions in the field of cardiovascular medicine. 

Post Your Comment